Breaking News, Collaborations & Alliances

TriLink & International Vaccine Institute Sign Memorandum of Understanding

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.

By: Rachel Klemovitch

Assistant Editor

Dr. Jerome Kim, Director General of IVI (left), standing next to TriLink’s Chief Commercial Officer, Becky Buzzeo, after signing the 'Memorandum of Understanding to Support the Development of mRNA-based Vaccines.'

TriLink BioTechnologies (TriLink) and the International Vaccine Institute (IVI), a non-profit international organization devoted to the discovery, development, and delivery of vaccines for global health, signed a Memorandum of Understanding (MOU).  Together, the companies will collaborate to advance the research and development of mRNA-based vaccines and promote equitable access to essential vaccines and health technologies. According to the terms of the MOU, TriLink and IVI will enter dis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters